Skip to search formSkip to main contentSkip to account menu

Haemophilus B Conjugate Vaccine

Known as: Haemophilus influenzae b vaccine, Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP), Haemophilus b oligosaccharide conjugate vacccine 
A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
This report presents new recommendations adopted in June 2009 by CDC's Advisory Committee on Immunization Practices (ACIP… 
2003
2003
We evaluated the effect of introduction of a combined hepatitis B-Haemophilus influenzae b vaccine on vaccine coverage rates in a… 
1998
1998
Objective. We report our experience with routine immunization of 89 premature infants in the neonatal intensive care unit because… 
1996
1996
  • MMWR. Morbidity and mortality weekly report
  • 1996
  • Corpus ID: 30448641
On September 27, 1996, the Food and Drug Administration (FDA) licensed a Haemophilus b Conjugate Vaccine (ActHIB) combined by… 
Highly Cited
1994
Highly Cited
1994
Because inactivated poliovirus vaccine (IPV) and Haemophilus influenzae b vaccine are advised in many programs and may be… 
1993
1993
These recommendations include information on two vaccines recently licensed for use among infants: Haemophilus b Conjugate… 
1991
1991
  • MMWR Recommendations and Reports
  • 1991
  • Corpus ID: 46326942
These recommendations include information on use of two vaccines recently licensed for use with infants: Haemophilus b Conjugate… 
1991
1991
The reported frequency of invasive Haemophilus influenzae type b disease occurring within 1 year after immunization was compared… 
1990
1990
Children younger than 2 years of age with previous invasive Haemophilus influenzae (Hib) type b disease may not develop…